Median changes in measures from baseline to end point according to whether participant was randomised to placebo or prednisone
| Measure | Placebo(N = 16) | Prednisone(N = 15) |
| Physical function score (0–10)) | 0.33 | 0.00 |
| Pain VAS score (0–10) | 0.50 | 0.10 |
| Patient global VAS score (0–10) | 0.65 | 0.00 |
| RAPID3 composite score (0–30) | 1.20 | 0.54 |
| Fatigue VAS score (0–10) | 0.45 | 0.00 |
| Morning stiffness (minutes) | 0.00 | 0.00 |
| Erythrocyte sedimentation rate | −2.00 | 0.00 |
| C-reactive protein | 0.25 | −0.30 |
No differences between groups were statistically significant (all p<0.05).
Negative sign indicates clinical improvement.
RAPID3, routine assessment of patient index data 3; VAS, visual analogue scale.